Stilla Technologies commercializes a revolutionnary dPCR systemStilla Technologies commercializes a revolutionnary dPCR systemJune 2016, Article on La Gazette du LaboratoireGet the PDF fileStilla2018-07-27T14:45:44+02:00September 7th, 2017|Press releases| Related PostsStilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones. Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones. Stilla’s webinar in collaboration with GenomeWeb & LGC London on Thursday 27th of February 2020 Expansion of the Management Team at Stilla Technologies Stilla technologies has been picked as the Spotlight of the month by Illumina Ventures Gallery Stilla technologies has been picked as the Spotlight of the month by Illumina Ventures
